CLINICAL_TRIALS trial_result · 2021-03-23

Clinical Trial Update: Study of the Safety & Efficacy of Leukine® in the Treatment of Alzheimer's Disease [Phase 2]

Phase 2 trial assessing safety and efficacy of Leukine in Alzheimer's disease has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: University of Colorado, Denver | Conditions: Alzheimer's Disease | Phase 2 | Status: COMPLETED | Results posted: 2021-03-23